165 related articles for article (PubMed ID: 19448594)
1. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma.
Newman MD; Lertsburapa T; Mirzabeigi M; Mafee M; Guitart J; Gerami P
Mod Pathol; 2009 Aug; 22(8):989-95. PubMed ID: 19448594
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
3. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
4. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma.
Yélamos O; Busam KJ; Lee C; Meldi Sholl L; Amin SM; Merkel EA; Obregon R; Guitart J; Gerami P
J Cutan Pathol; 2015 Nov; 42(11):796-806. PubMed ID: 26356543
[TBL] [Abstract][Full Text] [Related]
5. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
[No Abstract] [Full Text] [Related]
6. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
7. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Lee JJ; Cook M; Mihm MC; Xu S; Zhan Q; Wang TJ; Murphy GF; Lian CG
Oncotarget; 2015 Nov; 6(35):37995-8004. PubMed ID: 26462027
[TBL] [Abstract][Full Text] [Related]
8. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
Fang Y; Dusza S; Jhanwar S; Busam KJ
Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
[TBL] [Abstract][Full Text] [Related]
10. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
11. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
16. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
18. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
19. Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma).
Pennacchia I; Garcovich S; Gasbarra R; Leone A; Arena V; Massi G
Virchows Arch; 2012 Oct; 461(4):433-9. PubMed ID: 22892832
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]